참고문헌
- Glozier N, Tofler GH, Colquhoun DM, Bunker SJ, Clarke DM, Hare DL, et al. Psychosocial risk factors for coronary heart disease. Med J Aust 2013;199:179-80. https://doi.org/10.5694/mja13.10440
- Swift DL, Lavie CJ, Johannsen NM, Arena R, Earnest CP, O'Keefe JH, et al. Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J 2013;77:281-92. https://doi.org/10.1253/circj.CJ-13-0007
- Hansen D, Dendale P, Berger J, Meeusen R. Rehabilitation in cardiac patients:what do we know about training modalities? Sports Med 2005;35:1063-84. https://doi.org/10.2165/00007256-200535120-00005
- Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011;(7):CD001800.
- Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J 2011;162:571-584. https://doi.org/10.1016/j.ahj.2011.07.017
- Soares D, Viamonte S, Magalhaes S, Ribeiro MM, Barreira A, Fernandes P, et al. What factors determine the levels of physical activity after cardiac rehabilitation program? Acta Med Port 2013;26:689-98.
- Cipriano G Jr, Cipriano VT, da Silva VZ, Cipriano GF, Chiappa GR, de Lima AC, et al. Aerobic exercise effect on prognostic markers for systolic heart failure patients: a systematic review and meta-analysis. Heart Fail Rev 2014;19:655-67.
- Santaularia N, Jaarsma T. Motivational factors for exercise in cardiac patients? A literature review. Eur J Prev Med 2013;1:1-19. https://doi.org/10.11648/j.ejpm.20130101.11
- Heger Z, Cernei N, Kudr J, Gumulec J, Blazkova I, Zitka O, et al. A novel insight into the cardiotoxicity of antineoplastic drug doxorubicin. Int J Mol Sci 2013;14:21629-46. https://doi.org/10.3390/ijms141121629
- Zhang YW, Shi J, Li YJ, Wei L. Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch Immunol Ther Exp (Warsz) 2009;57:435-45. https://doi.org/10.1007/s00005-009-0051-8
- Lebrecht D, Walker UA. Role of mtDNA lesions in anthracycline cardiotoxicity. Cardiovasc Toxicol 2007;7:108-13. https://doi.org/10.1007/s12012-007-0009-1
- Fouad AA, Albuali WH, Al-Mulhim AS, Jresat I. Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity. Environ Toxicol Pharmacol 2013;36:347-57. https://doi.org/10.1016/j.etap.2013.04.018
- Albeck DS, Sano K, Prewitt GE, Dalton L. Mild forced treadmill exercise enhances spatial learning in the aged rat. Behav Brain Res 2006;168:345-8. https://doi.org/10.1016/j.bbr.2005.11.008
- Singal PK, Gupta M, Prasad K. Effects of increase in extracellular calcium on frequency-dependent inotropism in cardiac muscle. Can J Cardiol 1985;1:294-7.
- Dhalla NS, Singal PK, Panagia V, Harrow JA, Anand-Srivastava MB, Beamish RE. Progress and problems in understanding the involvement of calcium in heart function. Can J Physiol Pharmacol 1984;62:867-73. https://doi.org/10.1139/y84-146
- Vedam K, Nishijima Y, Druhan LJ, Khan M, Moldovan NI, Zweier JL, et al. Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice. Am J Physiol Heart Circ Physiol 2010;298:H1832-41. https://doi.org/10.1152/ajpheart.01047.2009
- Dudka J, Gieroba R, Korga A, Burdan F, Matysiak W, Jodlowska-Jedrych B, et al. Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity. Evid Based Complement Alternat Med 2012;2012:606183.
- Ohno H, Yamashita H, Ookawara T, Saitoh D, Mimura K, Taniguchi N. Effects of brief physical exercise on the concentrations of immunoreactive superoxide dismutase isoenzymes in human plasma. Tohoku J Exp Med 1992;167:301-3. https://doi.org/10.1620/tjem.167.301
- Berthiaume JM, Wallace KB. Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment. Cardiovasc Toxicol 2007;7:178-91. https://doi.org/10.1007/s12012-007-0026-0
-
Al-Shabanah OA, Aleisa AM, Hafez MM, Al-Rejaie SS, Al-Yahya AA, Bakheet SA, et al. Desferrioxamine attenuates doxorubicin-induced acute cardiotoxicity through TFG-
${\beta}$ /Smad p53 pathway in rat model. Oxid Med Cell Longev 2012;2012:619185. - Pointon AV, Walker TM, Phillips KM, Luo J, Riley J, Zhang SD, et al. Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activation. PLoS One 2010;5:e12733. https://doi.org/10.1371/journal.pone.0012733
- Thompson KL, Rosenzweig BA, Zhang J, Knapton AD, Honchel R, Lipshultz SE, et al. Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats. Cancer Chemother Pharmacol 2010;66:303-14. https://doi.org/10.1007/s00280-009-1164-9
- Sen CK, Atalay M, Hanninen O. Exercise-induced oxidative stress: glutathione supplementation and deficiency. J Appl Physiol (1985) 1994;77:2177-87. https://doi.org/10.1152/jappl.1994.77.5.2177
- Gleeson M. Immune function in sport and exercise. J Appl Physiol (1985) 2007;103:693-9. https://doi.org/10.1152/japplphysiol.00008.2007
- Ronsen O, Haug E, Pedersen BK, Bahr R. Increased neuroendocrine response to a repeated bout of endurance exercise. Med Sci Sports Exerc 2001;33:568-75.
- Pedersen BK, Bruunsgaard H. How physical exercise influences the establishment of infections. Sports Med 1995;19:393-400. https://doi.org/10.2165/00007256-199519060-00003
-
Sureda A, Ferrer MD, Tauler P, Romaguera D, Drobnic F, Pujol P, et al. Effects of exercise intensity on lymphocyte
$H_2O_2$ production and antioxidant defences in soccer players. Br J Sports Med 2009;43:186-90. https://doi.org/10.1136/bjsm.2007.043943 - Evans WJ. Vitamin E, vitamin C, and exercise. Am J Clin Nutr 2000;72(2 Suppl):647S-52S. https://doi.org/10.1093/ajcn/72.2.647S